Top Markets
#1 Threshold Network Threshold Network +48.26%
#2 TENDIES TENDIES +47.46%
#3 Mubarak Mubarak +19.04%
#4 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#5 OSK OSK +16.18%
#6 Kinetiq Kinetiq +15.12%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 MultiversX MultiversX +11.47%
#9 Maple Finance Maple Finance +11.12%
#10 Magma Finance Magma Finance +10.48%
Coin of the day
Threshold Network Threshold Network
設定
言語
日本
通貨
USD
テーマ
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
株式のランク #17486
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
株価
$0.8034
時価総額
$236.69M
変化（1日）
-8.69%
変化（1年）
-22.00%
国
US
取引 Invivyd, Inc. (IVVD)

カテゴリー

Healthcare
Invivyd, Inc.（IVVD）の利益
2026 時点の利益 TTM: 0
Invivyd, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Invivyd, Inc. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH